14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACAD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for ACADIA Pharmaceuticals Inc. stock after losing 0.90%
(Updated on Apr 24, 2024)

Sell candidate since Apr 23, 2024 Loss -0.90% PDF

The ACADIA Pharmaceuticals Inc. stock price fell by -0.90% on the last day (Wednesday, 24th Apr 2024) from $16.74 to $16.59. During the last trading day the stock fluctuated 1.72% from a day low at $16.55 to a day high of $16.84. The price has fallen in 7 of the last 10 days and is down by -6.43% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -341 thousand shares and in total, 1 million shares were bought and sold for approximately $17.65 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -39.82% during the next 3 months and, with a 90% probability hold a price between $8.58 and $11.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACAD Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ACADIA Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.93 and $18.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -37.06%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for ACADIA Pharmaceuticals Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.285 between high and low, or 1.72%. For the last week, the stock has had daily average volatility of 2.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACAD) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect ACADIA Pharmaceuticals Inc. to open at $16.66, and during the day (based on 14 day Average True Range), to move between $15.98 and $17.20, which gives a possible trading interval of +/-$0.611 (+/-3.68%) up or down from last closing price. If ACADIA Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 7.37% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $16.82, some $0.230 (1.39%) from the current price of $16.59, our system finds the risk reward not very attractive.

Is ACADIA Pharmaceuticals Inc. stock A Buy?

ACADIA Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.654 Sell Candidate Unchanged

Predicted Opening Price for ACADIA Pharmaceuticals Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$16.66 ( 0.412%) $16.59

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACAD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.94 2.13 %
R2 16.83 1.47 %
R1 16.77 1.07 %
Current price: 16.59
Support S1 16.55 -0.244 %
S2 16.48 -0.650 %
S3 16.37 -1.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 19.98 20.43 %
R2 18.48 11.39 %
R1 16.82 1.39 %
Current price 16.59
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ACADIA Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for ACADIA Pharmaceuticals Inc. is ACAD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ACADIA Pharmaceuticals Inc. Stock.

What's the current price of ACADIA Pharmaceuticals Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an ACADIA Pharmaceuticals Inc. (ACAD) share was $16.59.

What is the 52-week high and low for ACADIA Pharmaceuticals Inc. Stock?
The 52-week high for ACADIA Pharmaceuticals Inc. Stock is $33.91 and the 52-week low is $16.55.

What is the market capitalization of ACADIA Pharmaceuticals Inc. Stock?
As of the Apr 24, 2024, the market capitalization of ACADIA Pharmaceuticals Inc. is 2.734B.

When is the next earnings date for ACADIA Pharmaceuticals Inc.?
The upcoming earnings date for ACADIA Pharmaceuticals Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT